| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |